Assembly Biosciences (ASMB) Depreciation & Amortization (CF) (2010 - 2026)

Assembly Biosciences' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $26000.0 for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 21.21% year-over-year to $26000.0 in Q1 2026; TTM through Mar 2026 was $122000.0, a 6.15% decrease from a year earlier, with the FY2025 full-year figure at $129000.0, changed 0.0% from the prior year.
• Depreciation & Amortization (CF) slipped to $26000.0 in Q1 2026 per ASMB's latest filing, from $32000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $134000.0 in Q3 2022 and bottomed at $26000.0 in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $33000.0 (2024), against an average of $72470.6.
• Across the five-year window, Depreciation & Amortization (CF) gained 12.61% in 2022 and sank 74.6% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $124000.0 in 2022, then plunged by 32.26% to $84000.0 in 2023, then tumbled by 61.9% to $32000.0 in 2024, then changed by 0.0% to $32000.0 in 2025, then retreated by 18.75% to $26000.0 in 2026.
• Per Business Quant, the three latest ASMB Depreciation & Amortization (CF) figures stand at $26000.0 (Q1 2026), $32000.0 (Q4 2025), and $32000.0 (Q3 2025).